web analytics
15.8 C
Munich
Saturday, July 24, 2021
type here...

TAG

CYDY

BioPharma

CytoDyn’s Robust Platform Technology Keeps Expanding Into Breakthrough Therapy Designation Territory

Tom Rieder -
Leronlimab is an immunomodulator that targets many diseases Multiple indications being pursued in parallel Proven safety profile, novel mechanism of action, & ease...
Media & Technology

CytoDyn Inc (OTCMKTS: CYDY) Gaining as Vyrologix (leronlimab-PRO 140) Top Line Data Looms

James Elliot -
CytoDyn Inc (OTCMKTS: CYDY) is making an explosive move up the charts in recent weeks on a massive wave of buy volume and heavy...
Media & Technology

Powerful Rise on CytoDyn Inc (OTCMKTS: CYDY) as Vyrologix™ (leronlimab-PRO 140) Gains Traction

Daniel McCarthy -
CytoDyn Inc (OTCMKTS: CYDY) is in full beast mode skyrocketing up the charts on record setting volume easily surpassing all 3 moving averages and...
Media & Technology

Comeback Time for CytoDyn Inc (OTCMKTS:CYDY) NP Talks BLA for the USA, UK and Canada

Boe Rimes -
CytoDyn Inc (OTCMKTS:CYDY) is making an explosive move up the charts since a brief dip below $1.70 per share. New coronavirus cases have been...
Media & Technology

Bulls Take Charge of CytoDyn Inc (OTCMKTS:CYDY) as Leronlimab Gains Traction

James Elliot -
CytoDyn Inc (OTCMKTS:CYDY) is moving northbound in recent trading as the Company continues to announce promising results for Leronlimab as a treatment for coronavirus....
Media & Technology

Leronlimab; Positive CC Put CytoDyn Inc (OTCMKTS:CYDY) Back on Track

Boe Rimes -
CytoDyn Inc (OTCMKTS:CYDY) is heating up fast on a surge of volume and is heading upwards again after 2 weeks of choppy waters. With...
123Page 1 of 3

Latest news

© All rights reserved.

About Us

Popular Category

Editor Picks